Commercialization Under Compression: The New Operating System for Launch, Access, and Growth

Senior commercialization, market access, and commercial strategy leaders convened as part of the Fierce Pharma Week Commercialization Advisory Board to assess the structural forces reshaping how biopharma brings products to market.

Commercialization is moving into a harder, faster era where legacy playbooks break down under policy volatility, shrinking HCP access, accelerating channel disruption, and rising evidence demands. Competitive advantage now comes from building an operating system that can make disciplined bets early, pivot quickly, and translate evidence into access and adoption.